Rapid antigen tests have become a crucial tool around the world in managing COVID-19, but Australia is only using them in some industries and workplaces.
That’s despite the fact an Australian company created the first rapid COVID test to receive approval for home use in the United States last year.
The Brisbane-based digital diagnostics firm Ellume has a deal with the Biden administration to provide 8.5 million home COVID tests, and its new US manufacturing facility is set to begin production later this year.
CEDA CEO Melinda Cilento spoke with its founder and chief executive, Dr Sean Parsons, about the potential of rapid testing in Australia and his experience developing and manufacturing this technology.
But first Melinda is joined by CEDA Chief Economist Jarrod Ball to talk about some of the other issues we are thinking about at CEDA this week.
